Cyanotech (OTCMKTS:CYAN) Announces Quarterly Earnings Results

Cyanotech (OTCMKTS:CYAN) announced its earnings results on Monday. The biotechnology company reported $999.00 EPS for the quarter, Zacks reports. Cyanotech had a negative return on equity of 21.74% and a negative net margin of 7.14%.

Cyanotech Stock Performance

Shares of CYAN stock remained flat at $0.52 on Monday. The stock had a trading volume of 3 shares, compared to its average volume of 1,013. Cyanotech has a 12 month low of $0.21 and a 12 month high of $0.57. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.29 and a current ratio of 1.01. The stock has a market cap of $3.84 million, a price-to-earnings ratio of -2.08 and a beta of 0.15. The company’s fifty day moving average price is $0.43 and its 200-day moving average price is $0.41.

About Cyanotech

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.